Pretreatment with nafamostat mesilate, a kallikrein inhibitor, to decrease withdrawal response associated with rocuronium

Purpose This randomized, double-blind, placebo-controlled study was conducted to examine the preventive effect of nafamostat mesilate, a kallikrein inhibitor, on the withdrawal response associated with rocuronium injection. Methods Ninety American Society of Anesthesiology (ASA) physical status I or...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of anesthesia 2010-08, Vol.24 (4), p.549-552
Hauptverfasser:	Kim, Yoon Hee, Go, Young Kwon, Lee, Jung Un, Chung, Woo Suk, Shin, Yong Sup, Han, Kyu Cheol, Shin, Ji Eun, Lee, Suk Hoon
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Androstanols - adverse effects Anesthesia Anesthesiology Critical Care Medicine Dextrose Double-Blind Method Emergency Medicine Female Glucose Glucose metabolism Guanidines - pharmacology Humans Intensive Kallikrein Kallikreins - antagonists & inhibitors Male Medicine Medicine & Public Health Middle Aged Neuromuscular blocking agents Neuromuscular Nondepolarizing Agents - adverse effects Original Article Pain Medicine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!